Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Sep 26 2019

Full Issue

Defendants Object To Massive Volume Of Documents In Upcoming Landmark Federal Opioid Case

The number of witnesses in the upcoming case was trimmed down from 150 to 85 on Wednesday. Plaintiffs from two Ohio counties have accused the drug companies and distributors of creating a “public nuisance” that harmed the health of residents, and operated in concert, in much the same way as an illegal drug gang would. News on opioid-related issues focuses on a lost bid for a lawsuit, Chris Christie's $800,000 consulting contract with a drug maker, efforts to help family members, and more.

The Washington Post: Ohio Counties, Drug Companies Outline Arguments In Landmark Opioid Trial

With jury selection in a landmark opioid trial just three weeks away, lawyers for two Ohio counties said Wednesday they would prove that opioid manufacturers and distributors harmed public health and safety, and demanded they be held accountable. In new legal papers, Cuyahoga and Summit counties said that “the opioid epidemic . . . constitutes an unreasonable interference with public health, public safety, public peace or public comfort” that should be laid at the feet of the drug industry. (Bernstein, 9/25)

The Associated Press: State Loses Bid For Reargument In Opioid Lawsuit

A judge who granted Walgreens’ motion to dismiss in Delaware’s lawsuit against the drug industry over the opioid crisis has denied the state’s request for reargument. The judge said Wednesday that she did not overlook a controlling legal principle or misapprehend the law in dismissing Walgreens. (Chase, 9/26)

POLITICO Pro: How Chris Christie’s Influence On An Opioid Panel Landed Him An $800K Consulting Contract

Former New Jersey Gov. Chris Christie signed a lucrative consulting contract with a pharmaceutical company less than a year after President Donald Trump’s bipartisan commission on opioids and addiction, which Christie chaired, recommended policy changes the drugmaker sought. Pacira BioSciences paid Christie $800,000, plus stock options, in 2018 and 2019 as it lobbied for new Medicare rates to boost the financial prospects of its flagship product, a non-opioid painkiller used in surgeries, according to a POLITICO review of the New Jersey company’s regulatory filings. (Sutton, 9/26)

WBUR: In Township Ravaged By Opioids, Educators Create Program To Help Kids Cope

The rural township of Minford in southern Ohio started a program for children of parents and grandparents who are dealing with addiction. These kids are suffering emotional, behavioral and physical consequences of being raised by someone who suffers from addiction, says Marin Applegate, the district’s school psychologist. (Young, 9/25)

The Associated Press: Report: Opioids Settlement Won't Fix Areas Hardest Hit

OxyContin maker Purdue Pharma’s tentative legal settlement over the toll of the nation’s opioid crisis is unlikely to reverse the consequences of the epidemic in the hardest-hit towns and regions, according to a report released Wednesday. Purdue reached a tentative deal this month to resolve the lawsuits it faces. It could be worth up to $12 billion over time, with a portion of the benefits coming in savings on opioid antidotes for governments rather than cash. It would be up to a bankruptcy court judge to approve the plan, which continues to face significant opposition. (Mulvihill, 9/25)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, June 2
  • Monday, June 1
  • Friday, May 29
  • Thursday, May 28
  • Wednesday, May 27
  • Tuesday, May 26
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF